Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1195 (LINC01195) is a member of the long intergenic non-coding RNA (lincRNA) family, which are long RNA transcripts (>200 nucleotides) that do not overlap with annotated protein-coding genes and do not encode proteins[1][3][7][9]. LincRNAs are known to regulate gene expression through mechanisms such as chromatin remodeling, transcriptional regulation, and post-transcriptional RNA processing, frequently displaying tissue-specific expression patterns[3][7][9]. There is currently no evidence that LINC01195 is considered a therapeutic target, nor are there data implicating it as a biomarker or indicating interaction with drugs or disease processes in the available literature[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1195 (LINC01195).